These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19888930)

  • 1. White matter lesion load increases the risk of low CSF Aβ42 in apolipoprotein E-ɛ4 carriers attending a memory clinic.
    Stenset V; Hofoss D; Johnsen L; Berstad AE; Negaard A; Skinningsrud A; Gjerstad L; Fladby T
    J Neuroimaging; 2011 Apr; 21(2):e78-82. PubMed ID: 19888930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42.
    Stenset V; Johnsen L; Kocot D; Negaard A; Skinningsrud A; Gulbrandsen P; Wallin A; Fladby T
    Neurology; 2006 Sep; 67(5):830-3. PubMed ID: 16966546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in PSEN2 and correlation to CSF β-amyloid42 levels in AD.
    Lebedeva E; Stingl JC; Thal DR; Ghebremedhin E; Strauss J; Özer E; Bertram L; von Einem B; Tumani H; Otto M; Riepe MW; Högel J; Ludolph AC; von Arnim CA
    Neurobiol Aging; 2012 Jan; 33(1):201.e9-18. PubMed ID: 20850903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease.
    Yassine HN; Rawat V; Mack WJ; Quinn JF; Yurko-Mauro K; Bailey-Hall E; Aisen PS; Chui HC; Schneider LS
    Alzheimers Res Ther; 2016 Jun; 8():25. PubMed ID: 27358067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Abeta42 levels.
    Stenset V; Hofoss D; Johnsen L; Skinningsrud A; Berstad AE; Negaard A; Reinvang I; Gjerstad L; Fladby T
    Acta Neurol Scand; 2008 Dec; 118(6):373-8. PubMed ID: 18510598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype.
    Popp J; Lewczuk P; Frommann I; Kölsch H; Kornhuber J; Maier W; Jessen F
    J Alzheimers Dis; 2010; 22(2):459-68. PubMed ID: 21084733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease.
    Benedictus MR; Goos JD; Binnewijzend MA; Muller M; Barkhof F; Scheltens P; Prins ND; van der Flier WM
    Neurobiol Aging; 2013 Nov; 34(11):2488-94. PubMed ID: 23731952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.
    Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L
    J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
    Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
    Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42.
    Thorvaldsson V; Nordlund A; Reinvang I; Blennow K; Zetterberg H; Wallin A; Johansson B
    Int Psychogeriatr; 2010 Jun; 22(4):598-606. PubMed ID: 20338079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI.
    Herukka SK; Helisalmi S; Hallikainen M; Tervo S; Soininen H; Pirttilä T
    Neurobiol Aging; 2007 Apr; 28(4):507-14. PubMed ID: 16546302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
    Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.
    Kester MI; Blankenstein MA; Bouwman FH; van Elk EJ; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2009; 16(3):601-7. PubMed ID: 19276554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein Eepsilon4 carriers and non-carriers.
    Sohrabi HR; Bates KA; Rodrigues M; Taddei K; Martins G; Laws SM; Lautenschlager NT; Dhaliwal SS; Foster JK; Martins RN
    J Alzheimers Dis; 2009; 17(1):69-79. PubMed ID: 19494432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
    Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
    J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
    Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
    J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.
    Ramakers IH; Visser PJ; Aalten P; Bekers O; Sleegers K; van Broeckhoven CL; Jolles J; Verhey FR
    Dement Geriatr Cogn Disord; 2008; 26(2):101-8. PubMed ID: 18617739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.